Short Interest in AquaBounty Technologies, Inc. (NASDAQ:AQB) Drops By 47.4%

AquaBounty Technologies, Inc. (NASDAQ:AQB) was the target of a large drop in short interest in the month of February. As of February 13th, there was short interest totaling 9,108 shares, a drop of 47.4% from the January 29th total of 17,318 shares. Based on an average daily trading volume, of 34,098 shares, the short-interest ratio is presently 0.3 days. Currently, 0.2% of the company’s shares are sold short. Currently, 0.2% of the company’s shares are sold short. Based on an average daily trading volume, of 34,098 shares, the short-interest ratio is presently 0.3 days.

Institutional Trading of AquaBounty Technologies

A hedge fund recently raised its stake in AquaBounty Technologies stock. Renaissance Technologies LLC lifted its stake in shares of AquaBounty Technologies, Inc. (NASDAQ:AQB) by 311.9% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 121,585 shares of the company’s stock after acquiring an additional 92,065 shares during the period. Renaissance Technologies LLC owned 3.14% of AquaBounty Technologies worth $113,000 at the end of the most recent reporting period. Institutional investors own 8.92% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of AquaBounty Technologies in a research report on Monday, December 22nd. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, AquaBounty Technologies has a consensus rating of “Sell”.

AquaBounty Technologies Price Performance

NASDAQ AQB opened at $1.02 on Friday. The business has a 50 day simple moving average of $0.93 and a 200 day simple moving average of $1.14. AquaBounty Technologies has a one year low of $0.50 and a one year high of $2.95. The stock has a market capitalization of $3.96 million, a P/E ratio of -1.23 and a beta of 1.28.

AquaBounty Technologies Company Profile

AquaBounty Technologies, Inc is a biotechnology company focused on aquaculture innovation through the development and commercialization of genetically engineered fish. Its flagship product, AquAdvantage Salmon, is an Atlantic salmon strain enhanced with a growth hormone gene that enables faster growth and more efficient feed conversion compared with conventional farmed salmon. By integrating biotechnology into seafood production, AquaBounty aims to address global protein demand while reducing the environmental footprint associated with marine aquaculture.

Founded in 1991, AquaBounty is headquartered in Maynard, Massachusetts, and operates a state-of-the-art, land-based incubation and grow-out facility in Panama.